Skip to content
Hair Pipeline

The geography of the field

Where hair-regeneration programmes are being developed, and — separately — where any of it has actually been authorised. The two maps barely overlap, which is the honest summary of this field: the work is concentrated in a handful of countries, and whether it reaches you depends on a regulator that has never heard of most of it.

Canada — 2 programmesUnited States — 38 programmesBrazil — 4 programmesFrance — 1 programmeSouth Korea — 8 programmesIndia — 1 programmeSweden — 1 programmeGermany — 1 programmeSwitzerland — 2 programmesSpain — 2 programmesIreland — 1 programmeChina — 7 programmesTaiwan — 1 programmeDenmark — 1 programmeUnited Kingdom — 3 programmesJapan — 1 programme
Programmes in developmentAt least one authorised treatment

Where the work is done

  • United States38Stemson Therapeutics · Aneira Pharma · Biosplice Therapeutics · Veradermics · Organon · Bristol Myers Squibb · Amgen · AnaptysBio · Equillium · Priovant Therapeutics · ImageneBio · Pelage Pharmaceuticals · AbbVie · Pfizer · Eli Lilly · Incyte · DermaLiq Therapeutics · Aclaris Therapeutics · Eirion Therapeutics · Applied Biology · Amplifica · TechnoDerma Medicines · Aldena Therapeutics · Throne Biotechnologies · Absci · Xtressé · Johnson & Johnson · Histogen · Aderans Research Institute · TetraLogic Pharmaceuticals · Nektar Therapeutics · Q32 Bio · Neosil
  • South Korea8Epibiotech · Chong Kun Dang Pharmaceutical · Addpharma · NEXTGEN Bioscience · Olix Pharmaceuticals · Moogene Medi · Inventage Lab
  • China7Jiangsu Vcare Pharmaceutical · Suzhou Zelgen Biopharmaceuticals · Kintor Pharmaceutical · Hope Medicine · CSPC Pharmaceutical Group · Kelun-Biotech
  • Brazil4EMS · Biolab Sanus Farmacêutica · Eurofarma Laboratórios · Apsen Farmacêutica
  • United Kingdom3Soterios Pharma · HairClone · GSK
  • Canada2Triple Hair · RepliCel Life Sciences
  • Switzerland2Legacy Healthcare
  • Spain2Almirall
  • France1Sanofi
  • Japan1OrganTech
  • country.AE1PDFE Pharma Innovations
  • Germany1TissUse
  • Denmark1LEO Pharma
  • Ireland1Cosmo Pharmaceuticals
  • India1Sun Pharmaceutical
  • Sweden1Follicum
  • Singapore1ASLAN Pharmaceuticals
  • Taiwan1Energenesis Biomedical

Where treatments are authorised

Counted from the register's approval records, which currently cover the marketed standards and the approved JAK inhibitors. Absence here means we have not recorded an authorisation, not that none exists.

  • United StatesFDA5 authorised · 3 off-label
  • South KoreaMFDS1 authorised
  • ChinaNMPA1 authorised
  • United KingdomMHRA1 authorised
  • FranceANSM, EMA4 authorised · 1 off-label
  • JapanPMDA1 authorised
  • European UnionEMA3 authorised